Form 4: Lilly Endowment Inc. Sells Shares of Eli Lilly & Co (LLY)

Lilly Endowment Inc., a 10% owner of Eli Lilly & Co, reports selling shares in multiple transactions on February 24, 2025.

Summary

• Lilly Endowment Inc., a 10% owner of Eli Lilly & Co (LLY), filed a Form 4 indicating changes in beneficial ownership.
• On February 24, 2025, Lilly Endowment Inc. sold multiple blocks of Eli Lilly & Co common stock.
• The sales occurred at various weighted average prices ranging from $877.311 to $891.874 per share.
• A total of 60,326 shares were sold on this date.
• Following these transactions, Lilly Endowment Inc. still beneficially owns 96,461,978 shares of Eli Lilly & Co.
• The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price within the specified ranges upon request.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting the sale of shares by a major shareholder. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell the company's stock. These filings provide transparency to the market regarding the transactions of those with privileged information.

Stakeholder Impact

• The sale of shares by a major shareholder like Lilly Endowment Inc. could potentially create downward pressure on the stock price in the short term.
• However, the long-term impact is likely to be minimal given the large number of shares still held by Lilly Endowment Inc.

Key Dates